1. Drug Therapy and Optimization

1. Evaluation of drug therapy in the management of type 2 diabetes mellitus in Indian patients.
2. Assessment of adherence to antihypertensive therapy and its impact on blood pressure control in Indian populations.
3. Study on the clinical outcomes of anticoagulation therapy in patients with atrial fibrillation.
4. Comparative study of efficacy and safety of different insulin analogs in diabetes management.
5. Evaluation of prescribing patterns for proton pump inhibitors in Indian hospitals.
6. Optimization of antibiotic therapy in patients with multidrug-resistant bacterial infections.
7. Study on the impact of clinical pharmacist interventions in managing chronic obstructive pulmonary disease (COPD).
8. Evaluation of drug utilization patterns in patients with chronic kidney disease.
9. Assessment of the effectiveness of combination therapy in patients with resistant hypertension.
10. Study on the appropriateness of prescribing non-steroidal anti-inflammatory drugs (NSAIDs) in elderly patients.

2. Pharmacovigilance and Drug Safety

11. Study on adverse drug reactions (ADRs) reporting patterns in Indian tertiary care hospitals.
12. Role of clinical pharmacists in detecting and preventing ADRs in oncology settings.
13. Comparative analysis of ADR profiles of commonly used antibiotics in India.
14. Investigation of pharmacovigilance practices among healthcare professionals in India.
15. Study on the role of clinical pharmacists in minimizing medication errors in intensive care units (ICUs).
16. Analysis of ADRs associated with immunotherapy in cancer patients.
17. Evaluation of the safety profile of herbal medicines used in combination with allopathic drugs.
18. Study on the impact of pharmacovigilance programs in improving patient safety in Indian hospitals.
19. Investigation of risk factors for ADRs in pediatric patients on polypharmacy.
20. Role of pharmacovigilance in monitoring ADRs in geriatric patients.

3. Clinical Trials and Research

21. Study on the role of clinical pharmacists in improving patient recruitment and retention in clinical trials.
22. Comparative analysis of ethical considerations in clinical trials conducted in rural and urban India.
23. Evaluation of clinical trial compliance with the New Drugs and Clinical Trials Rules (2019).
24. Study on the outcomes of Phase IV clinical trials in post-marketing surveillance.
25. Assessment of the effectiveness of clinical pharmacist-driven interventions in clinical trial management.
26. Role of clinical pharmacists in monitoring patient safety during clinical trials.
27. Study on the challenges in conducting clinical trials for rare diseases in India.
28. Evaluation of patient-reported outcomes in clinical trials for oncology drugs.
29. Study on the role of clinical pharmacists in ensuring ethical compliance in clinical research.
30. Impact of clinical pharmacist-led education on the informed consent process in clinical trials.

4. Patient Counseling and Education

31. Role of clinical pharmacists in improving medication adherence through patient counseling.
32. Study on the impact of pharmacist-led diabetes education programs on glycemic control.
33. Evaluation of the role of clinical pharmacists in smoking cessation programs.
34. Study on the effectiveness of patient education in reducing medication-related errors in outpatient settings.
35. Role of clinical pharmacists in educating patients about drug-food interactions in chronic diseases.
36. Study on the impact of pharmacist-led counseling on lifestyle modification in hypertension management.
37. Evaluation of the effectiveness of clinical pharmacist-driven asthma management programs.
38. Study on the role of clinical pharmacists in educating patients about antimicrobial resistance.
39. Impact of pharmacist-led counseling on improving compliance with post-surgical medication regimens.
40. Study on the effectiveness of clinical pharmacist-driven weight management programs for obese patients.

5. Drug Utilization Studies

41. Evaluation of prescribing trends for antibiotics in tertiary care hospitals in India.
42. Study on drug utilization patterns in patients with cardiovascular diseases.
43. Assessment of psychotropic drug prescribing trends in mental health facilities in India.
44. Drug utilization review of anti-epileptic drugs in epilepsy management.
45. Study on the prescribing patterns of anti-diabetic medications in Indian hospitals.
46. Comparative drug utilization study of analgesics in postoperative pain management.
47. Evaluation of medication use patterns in ICU settings in Indian hospitals.
48. Study on the utilization patterns of lipid-lowering drugs in patients with dyslipidemia.
49. Assessment of prescribing practices in the treatment of upper respiratory tract infections.
50. Drug utilization review of medications used for rheumatoid arthritis in outpatient clinics.

6. Evidence-Based Practice

51. Study on the impact of evidence-based guidelines on the management of community-acquired pneumonia.
52. Evaluation of the role of clinical pharmacists in implementing evidence-based medicine in hospital settings.
53. Comparative study on the use of evidence-based guidelines for managing sepsis in Indian hospitals.
54. Study on the impact of clinical pharmacists in improving adherence to evidence-based cancer treatment protocols.
55. Role of clinical pharmacists in bridging the gap between evidence-based guidelines and clinical practice in diabetes management.
56. Study on the role of clinical pharmacists in reducing inappropriate polypharmacy in elderly patients.
57. Evaluation of evidence-based interventions for managing depression in primary care settings.
58. Study on the impact of evidence-based antimicrobial stewardship programs in Indian hospitals.
59. Role of clinical pharmacists in promoting evidence-based use of biosimilars.
60. Study on the implementation of evidence-based pain management strategies in cancer patients.

7. Geriatric and Pediatric Pharmacy

61. Study on the role of clinical pharmacists in optimizing therapy for elderly patients with polypharmacy.
62. Evaluation of the impact of clinical pharmacist interventions in managing geriatric depression.
63. Study on drug utilization patterns in pediatric patients with chronic diseases.
64. Assessment of the role of clinical pharmacists in managing pediatric asthma.
65. Study on the challenges of prescribing medications for geriatric patients with dementia.
66. Role of clinical pharmacists in reducing medication-related hospitalizations in elderly patients.
67. Study on the management of neonatal sepsis and the role of clinical pharmacists in optimizing therapy.
68. Evaluation of pediatric dosage forms and their impact on compliance in Indian settings.
69. Study on clinical pharmacist-driven interventions in managing pediatric epilepsy.
70. Role of clinical pharmacists in monitoring drug therapy in geriatric cancer patients.

8. Chronic Disease Management

71. Study on the role of clinical pharmacists in managing hypertension in rural Indian populations.
72. Evaluation of pharmacist-led interventions in managing chronic kidney disease.
73. Role of clinical pharmacists in optimizing therapy for heart failure patients.
74. Study on the impact of clinical pharmacist interventions in managing chronic pain.
75. Evaluation of the role of pharmacists in improving adherence to therapy in patients with HIV/AIDS.
76. Study on pharmacist-led interventions for managing patients with rheumatoid arthritis.
77. Role of clinical pharmacists in the management of thyroid disorders in Indian populations.
78. Study on pharmacist-led care in managing patients with metabolic syndrome.
79. Evaluation of the role of clinical pharmacists in improving quality of life for cancer patients.
80. Study on pharmacist-driven smoking cessation interventions for patients with chronic obstructive pulmonary disease (COPD).

9. Emerging Areas in Clinical Pharmacy

81. Study on the role of pharmacogenomics in optimizing drug therapy for Indian populations.
82. Role of clinical pharmacists in managing adverse effects of biologics.
83. Evaluation of the impact of telepharmacy in managing chronic diseases in rural India.
84. Study on the challenges of integrating pharmacogenomic data into clinical practice.
85. Role of clinical pharmacists in monitoring drug-drug interactions with novel oral anticoagulants.
86. Study on the effectiveness of mobile apps in improving patient adherence to therapy.
87. Evaluation of the role of clinical pharmacists in managing patients with rare diseases.
88. Study on the potential of artificial intelligence in optimizing drug therapy.
89. Role of clinical pharmacists in managing complications associated with gene therapy.
90. Study on the role of digital health tools in improving medication management.

10. Case Studies and Policy Analysis

91. Case study on the role of clinical pharmacists in managing ADRs in oncology settings.
92. Policy analysis of the New Drugs and Clinical Trials Rules (2019) from a clinical pharmacy perspective.
93. Role of clinical pharmacists in addressing gaps in rural healthcare in India.
94. Case study on the role of clinical pharmacists in improving medication adherence in tuberculosis patients.
95. Study on clinical pharmacists’ contributions to healthcare teams in Indian hospitals.
96. Policy review of antimicrobial stewardship programs in Indian healthcare settings.
97. Case study on the implementation of clinical pharmacist-driven diabetes management clinics.
98. Study on the economic impact of clinical pharmacist interventions in reducing hospital readmissions.
99. Policy analysis of the role of pharmacists in improving rational drug use in India.
100. Case study on clinical pharmacist-driven interventions in managing post-surgical infections.
101. Role of clinical pharmacists in addressing medication non-adherence in India: Challenges and solutions.